TARGETING BCL2 TO INCREASE ENZALUTAMIDE SENSITIVITY TO BETTER SUPPRESS PROSTATE CANCER PROGRESSION THROUGH ALTERING ARV7 PROTEIN DEGRADATION

被引:0
作者
Xu, Hua
机构
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PD59-11
引用
收藏
页码:E1209 / E1209
页数:1
相关论文
共 28 条
  • [21] Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
    Linyi Hu
    Yin Sun
    Jie Luo
    Xiang He
    Meihua Ye
    Gonghui Li
    Yong Zhang
    Jian Bai
    Dahong Zhang
    Chawnshang Chang
    Oncogene, 2020, 39 : 1891 - 1903
  • [22] TARGETING TR4 NUCLEAR RECEPTOR WITH ANTAGONIST BEXAROTENE INCREASES DOCETAXEL SENSITIVITY TO BETTER SUPPRESS THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION
    Hu, Linyi
    Sun, Yin
    Luo, Jie
    He, Xiang
    Ye, Meihua
    Li, Gonghui
    Zhang, Yong
    Bai, Jian
    Zhang, Dahong
    Chang, Chawnshang
    JOURNAL OF UROLOGY, 2021, 206 : E55 - E56
  • [23] Long non-coding RNA HOTAIR promotes cervical cancer progression through regulating BCL2 via targeting miR-143-3p
    Liu, Mingzhu
    Jia, Jinying
    Wang, Xinjie
    Liu, Yanjie
    Wang, Chunfang
    Fan, Ruitai
    CANCER BIOLOGY & THERAPY, 2018, 19 (05) : 391 - 399
  • [24] High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling
    Chen, Lei
    Sun, Yin
    Tang, Min
    Wu, Denglong
    Xiang, Zhendong
    Huang, Chi-Ping
    You, Bosen
    Xie, Dongdong
    Ye, Qinglin
    Yu, Dexin
    Chang, Chawnshang
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [25] High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling
    Lei Chen
    Yin Sun
    Min Tang
    Denglong Wu
    Zhendong Xiang
    Chi-Ping Huang
    Bosen You
    Dongdong Xie
    Qinglin Ye
    Dexin Yu
    Chawnshang Chang
    Cell Death Discovery, 8
  • [26] Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression
    Wang, Ronghao
    Sun, Yin
    Li, Lei
    Niu, Yuanjie
    Lin, Wanying
    Lin, Changyi
    Antonarakis, Emmanuel S.
    Luo, Jun
    Yeh, Shuyuan
    Chang, Chawnshang
    EUROPEAN UROLOGY, 2017, 72 (05) : 835 - 844
  • [27] Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through matrix metalloproteinase (MMP-2) mediated extracellular matrix degradation
    Ito, Yusuke
    Ishiguro, Hitoshi
    Kobayashi, Naohito
    Hasumi, Hisashi
    Watanabe, Masatoshi
    Yao, Masahiro
    Uemura, Hiroji
    CANCER RESEARCH, 2015, 75
  • [28] Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3′-UTRs of RAC2/BCL2L1 and the coding region of PAK4
    Zhang, Xu
    Fang, Jiajie
    Chen, Shiming
    Wang, Weiyu
    Meng, Shuai
    Liu, Ben
    CANCER MEDICINE, 2019, 8 (12): : 5716 - 5734